XDNA.TO iShares Genomics Immunology and Healthcare Index ETF CAD

ETF Healthcare Equity BlackRock Asset Management Canada Ltd Toronto Exchange
- CAD
No recent price
Total assets
17.4M
Expense ratio
-
Dividend yield
0.19%
1-year return
+75.65%
Holdings
10
Since
2022

Fund data as reported by the issuer, updated Nov 11, 2026. Total assets are in the fund's base currency.

What does XDNA.TO invest in?

Tracks Morningstar Gbl Health GR CAD
  • Mostly US Equity (69.4%)
  • Largest sector: Healthcare (100.0%)
  • Largest region: North America (67.7%)
  • Top 3 holdings: 25.9% of the fund

Asset allocation

  • US Equity 69.4%
  • Equity 2.3%
  • Cash 0.2%

Top holdings

  • Moderna Inc 12.91%
  • Genmab A/S 6.65%
  • Twist Bioscience Corp 6.33%
  • Regeneron Pharmaceuticals Inc 3.81%
  • Takeda Pharmaceutical Co. Ltd. 3.78%
All holdings, sectors and regions

iShares Genomics Immunology and Healthcare Index ETF CAD performance

Sharpe ratio 1.27
This year
+70.94%
1 year
+75.65%
3 years
+36.85%
5 years
0.00%

Volatility 28.3% over 1 year and 23.9% over 3 years. High: expect large swings.

Total returns in the fund's currency as reported by the issuer; past returns do not predict future returns. Volatility is the yearly standard deviation of returns. Ask AI to explain these numbers

XDNA.TO price

Prices on the chart can differ slightly from the closing prices StockSummer shows.